This Is By Far My #1 Income Stock
This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year. And today, I want to give you the name, the ticker symbol and my full analysis completely free - no strings attached.
Click here to get it.
pixel

HRTX Insider Trading (Heron Therapeutics)

Insider Ownership Percentage: 12.85%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $121,726.43

Heron Therapeutics Insider Trading History Chart

Heron Therapeutics Share Price & Price History

$15.42
▲ +0.49 (3.28%)
As of 06/21/2021 04:40 PM ET
Days: 30 | 90 | 365
Finance PhD: “Move your money BEFORE June 30th ”
The clock just started on the biggest financial event in 20 years. And the next months could decide your wealth in 2021.
Here’s what to do now.

Heron Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2021Kimberly ManhardEVPSell1,529$17.66$27,002.143,163View SEC Filing Icon  
4/15/2021Waage ChristianDirectorSell300$17.51$5,253.004,100View SEC Filing Icon  
4/6/2021Craig A JohnsonDirectorSell250$17.22$4,305.003,590View SEC Filing Icon  
1/14/2021David Leslie SzekeresCOOSell827$18.09$14,960.431,250View SEC Filing Icon  
1/8/2021David Leslie SzekeresCOOSell3,571$19.66$70,205.86View SEC Filing Icon  
5/1/2020Kimberly ManhardVPSell1,158$13.97$16,177.261,158View SEC Filing Icon  
11/29/2019Kimberly ManhardVPSell24,000$26.00$624,000.0024,000View SEC Filing Icon  
10/4/2019Kevin C TangDirectorBuy285,714$17.50$4,999,995.00View SEC Filing Icon  
10/3/2019Barry D QuartCEOBuy4,571$17.50$79,992.5090,081View SEC Filing Icon  
10/3/2019John PoyhonenEVPBuy5,143$17.50$90,002.5018,143View SEC Filing Icon  
9/30/2019John PoyhonenInsiderBuy11,105$22.62$251,195.10
5/22/2019John PoyhonenDirectorBuy3,000$17.55$52,650.0013,000View SEC Filing Icon  
5/15/2019Waage ChristianDirectorBuy1,400$18.04$25,256.001,400View SEC Filing Icon  
5/1/2019Kimberly ManhardVPSell1,109$18.86$20,915.741,109View SEC Filing Icon  
11/2/2018Kimberly ManhardVPSell494$30.62$15,126.28494View SEC Filing Icon  
10/1/2018Kimberly ManhardVPSell6,000$32.07$192,420.006,000View SEC Filing Icon  
9/12/2018Kevin C TangDirectorSell2,695,000$35.75$96,346,250.00View SEC Filing Icon  
7/2/2018Kimberly ManhardVPSell6,000$37.53$225,180.006,000View SEC Filing Icon  
7/2/2018Robert HoffmanCFOSell30,000$38.17$1,145,100.001,280View SEC Filing Icon  
7/2/2018Robert RosenPresidentSell225,000$38.98$8,770,500.00132,109View SEC Filing Icon  
6/29/2018Robert RosenPresidentSell129,469$39.59$5,125,677.71132,109View SEC Filing Icon  
6/21/2018Barry D QuartCEOSell50,000$39.05$1,952,500.0069,600View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Heron Therapeutics (NASDAQ:HRTX)

88.99% of Heron Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Heron Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/24/2021Principal Financial Group Inc.38,879$0.63M0.0%-5.1%0.038%Search for SEC Filing on Google Icon
5/19/2021Twin Lakes Capital Management LLC4,170$68K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC150,745$2.44M0.0%N/A0.148%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC1,039,846$16.86M0.0%+419.8%1.021%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.65,000$1.05M0.0%-41.1%0.064%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.2,207,390$35.78M0.0%-2.4%2.168%Search for SEC Filing on Google Icon
5/18/2021Highland Capital Management Fund Advisors L.P.609,531$9.88M2.6%-15.5%0.599%Search for SEC Filing on Google Icon
5/18/2021State of Wisconsin Investment Board117,900$1.91M0.0%-5.4%0.116%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley618,728$10.03M0.0%+34.6%0.608%Search for SEC Filing on Google Icon
5/18/2021Tudor Investment Corp Et Al51,690$0.84M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC37,819$0.61M0.0%+353.4%0.037%Search for SEC Filing on Google Icon
5/18/2021IHT Wealth Management LLC12,025$0.20M0.0%-42.9%0.012%Search for SEC Filing on Google Icon
5/18/2021FORA Capital LLC1,752$28K0.0%-88.2%0.002%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC36,028$0.58M0.0%N/A0.035%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada24,582$0.40M0.0%+33.1%0.024%Search for SEC Filing on Google Icon
5/17/2021Suvretta Capital Management LLC506,037$8.20M0.1%N/A0.497%Search for SEC Filing on Google Icon
5/17/2021Price T Rowe Associates Inc. MD57,421$0.93M0.0%-18.5%0.056%Search for SEC Filing on Google Icon
5/17/2021Ameriprise Financial Inc.84,022$1.36M0.0%-16.8%0.083%Search for SEC Filing on Google Icon
5/17/2021Hennion & Walsh Asset Management Inc.393,481$6.38M0.4%N/A0.386%Search for SEC Filing on Google Icon
5/17/2021DSAM Partners London Ltd283,415$4.59M0.9%-19.3%0.278%Search for SEC Filing on Google Icon
5/17/2021Beirne Wealth Consulting Services LLC12,500$0.20M0.1%-44.4%0.012%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC490,646$7.95M0.0%+10.4%0.482%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.1,225,285$19.86M0.0%+6.7%1.203%Search for SEC Filing on Google Icon
5/14/2021Weiss Multi Strategy Advisers LLC19,305$0.31M0.0%-3.9%0.019%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP613,184$9.94M0.0%+16.6%0.602%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd11,872$0.19M0.1%N/A0.012%Search for SEC Filing on Google Icon
5/14/2021UBS Asset Management Americas Inc.98,569$1.60M0.0%+4.4%0.097%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp87,125$1.41M0.0%+17.8%0.086%Search for SEC Filing on Google Icon
5/14/2021Credit Suisse AG65,271$1.06M0.0%-54.8%0.064%Search for SEC Filing on Google Icon
5/14/2021Rothschild & Co. Asset Management US Inc.1,037,795$16.82M0.2%-23.3%1.019%Search for SEC Filing on Google Icon
5/14/2021Quantbot Technologies LP3,771$61K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/13/2021Clearbridge Investments LLC3,436,925$55.71M0.0%-0.5%3.375%Search for SEC Filing on Google Icon
5/13/2021Guggenheim Capital LLC58,415$0.95M0.0%+73.1%0.057%Search for SEC Filing on Google Icon
5/13/2021Franklin Resources Inc.12,648,894$205.04M0.1%-0.3%12.422%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP28,393$0.46M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/13/2021SG Americas Securities LLC18,001$0.29M0.0%-69.9%0.018%Search for SEC Filing on Google Icon
5/13/2021AlphaCrest Capital Management LLC19,123$0.31M0.0%+86.8%0.019%Search for SEC Filing on Google Icon
5/13/2021ClariVest Asset Management LLC96,928$1.57M0.1%-24.8%0.095%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC138,626$2.25M0.0%+104.3%0.136%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC162,600$2.64M0.0%N/A0.160%Search for SEC Filing on Google Icon
5/13/2021Amalgamated Bank12,463$0.20M0.0%-9.0%0.012%Search for SEC Filing on Google Icon
5/13/2021Pekin Hardy Strauss Inc.520,805$8.44M1.3%+11.7%0.568%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp340,474$5.52M0.0%-4.2%0.371%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.247,239$4.01M0.0%+1,070.4%0.270%Search for SEC Filing on Google Icon
5/13/2021X Square Capital LLC15,799$0.26M0.1%+38.6%0.017%Search for SEC Filing on Google Icon
5/13/2021Bank of Montreal Can3,084$53K0.0%-78.2%0.003%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp957,017$15.51M0.0%-4.2%1.044%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC1,441,145$23.36M0.0%+10.5%1.572%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC50,000$0.81M0.6%+233.3%0.055%Search for SEC Filing on Google Icon
5/12/2021Palisade Capital Management LLC NJ1,063,734$17.24M0.4%+19.4%1.160%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.3,273,121$53.06M0.0%+5.6%3.570%Search for SEC Filing on Google Icon
5/12/2021Panagora Asset Management Inc.507,586$8.23M0.0%-1.8%0.554%Search for SEC Filing on Google Icon
5/12/2021E Fund Management Co. Ltd.8,185$0.13M0.0%N/A0.009%Search for SEC Filing on Google Icon
5/12/2021Sei Investments Co.272,958$4.43M0.0%-34.3%0.298%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG147,904$2.40M0.0%+12.5%0.161%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund251,831$4.08M0.0%+9.8%0.275%Search for SEC Filing on Google Icon
5/11/2021Cutter & CO Brokerage Inc.27,840$0.45M0.1%-16.5%0.030%Search for SEC Filing on Google Icon
5/11/2021Peak Financial Advisors LLC139,560$2.26M1.9%-22.4%0.152%Search for SEC Filing on Google Icon
5/11/2021Banque Cantonale Vaudoise3,000$48K0.0%+50.0%0.003%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.183,741$2.98M0.0%+2.9%0.200%Search for SEC Filing on Google Icon
5/10/2021Principal Financial Group Inc.38,879$0.63M0.0%-5.1%0.042%Search for SEC Filing on Google Icon
5/10/2021Rafferty Asset Management LLC196,692$3.19M0.0%+480.7%0.215%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP33,369$0.54M0.1%N/A0.036%Search for SEC Filing on Google Icon
5/10/2021Diversified Trust Co17,681$0.29M0.0%-5.5%0.019%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.7,137,310$115.70M0.0%+3.6%7.785%Search for SEC Filing on Google Icon
5/7/2021D.A. Davidson & CO.122,797$1.99M0.0%+38.8%0.134%Search for SEC Filing on Google Icon
5/7/2021Swiss National Bank197,200$3.20M0.0%+1.0%0.215%Search for SEC Filing on Google Icon
5/6/2021Blueshift Asset Management LLC28,221$0.46M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers104,876$1.70M0.0%-8.8%0.114%Search for SEC Filing on Google Icon
5/6/2021Estate Counselors LLC3,000$49K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/6/2021M&T Bank Corp21,545$0.35M0.0%+12.9%0.024%Search for SEC Filing on Google Icon
5/5/2021Los Angeles Capital Management LLC15,940$0.26M0.0%-37.9%0.017%Search for SEC Filing on Google Icon
5/4/2021Oak Ridge Investments LLC2,106,218$34.14M0.3%+690.6%2.297%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC30,915$0.50M0.0%+13.6%0.034%Search for SEC Filing on Google Icon
5/3/2021The Manufacturers Life Insurance Company49,038$0.80M0.0%-4.6%0.053%Search for SEC Filing on Google Icon
5/3/2021Zurcher Kantonalbank Zurich Cantonalbank9,714$0.16M0.0%-17.1%0.011%Search for SEC Filing on Google Icon
4/30/2021Signaturefd LLC4,375$71K0.0%+34.6%0.005%Search for SEC Filing on Google Icon
4/30/2021Virginia Retirement Systems ET AL20,900$0.34M0.0%-24.8%0.023%Search for SEC Filing on Google Icon
4/29/2021Handelsbanken Fonder AB21,700$0.35M0.0%+66.9%0.024%Search for SEC Filing on Google Icon
4/27/2021Fisher Asset Management LLC34,722$0.56M0.0%+5.0%0.038%Search for SEC Filing on Google Icon
4/27/2021State of New Jersey Common Pension Fund D124,256$2.01M0.0%-12.0%0.136%Search for SEC Filing on Google Icon
4/19/2021Congress Park Capital LLC192,647$3.12M1.7%-2.7%0.211%Search for SEC Filing on Google Icon
4/2/2021Private Asset Management Inc.192,853$3.13M0.4%+13.1%0.211%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP119,777$2.54M0.0%+56.8%0.131%Search for SEC Filing on Google Icon
3/19/2021Valley Brook Capital Group1,300$27K0.0%N/A0.001%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP525,892$11.13M0.0%-2.2%0.575%Search for SEC Filing on Google Icon
3/2/2021Norges Bank1,166,605$24.69M0.0%N/A1.276%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP525,892$11.13M0.0%-2.2%0.579%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC11,730$0.25M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC20,667$0.44M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/23/2021Pier 88 Investment Partners LLC48,410$1.03M0.2%+28.5%0.053%Search for SEC Filing on Google Icon
2/23/2021Principal Financial Group Inc.40,953$0.87M0.0%+26.0%0.045%Search for SEC Filing on Google Icon
2/19/2021PFM Health Sciences LP2,011,477$42.57M1.5%+7.5%2.214%Search for SEC Filing on Google Icon
2/19/2021UBS Oconnor LLC600,000$12.70M0.2%-7.7%0.660%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.3,100,782$65.63M0.0%+4.1%3.413%Search for SEC Filing on Google Icon
2/18/2021Truist Financial Corp22,801$0.48M0.0%+51.5%0.025%Search for SEC Filing on Google Icon
2/17/2021IHT Wealth Management LLC21,061$0.45M0.0%+77.1%0.023%Search for SEC Filing on Google Icon
2/17/2021UBS Oconnor LLC600,000$12.70M0.4%-7.7%0.660%Search for SEC Filing on Google Icon
2/16/2021Morgan Stanley459,763$9.73M0.0%+144.7%0.506%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC444,535$9.41M0.0%-41.7%0.489%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Heron Therapeutics logo
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing HTX-011, an investigational, dual-acting, and fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam, which is in Phase III clinical trials for pain management; and HTX-034, which is in Phase Ib/II clinical trials for postoperative pain management. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Read More on Heron Therapeutics

Today's Range

Now: $15.42
$14.77
$15.47

50 Day Range

MA: $15.74
$13.27
$18.48

52 Week Range

Now: $15.42
$12.52
$22.40

Volume

27,766 shs

Average Volume

1,351,928 shs

Market Capitalization

$1.57 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Who are the company insiders with the largest holdings of Heron Therapeutics?

Heron Therapeutics' top insider shareholders include:
  1. Barry D Quart (CEO)
  2. Kimberly Manhard (VP)
  3. John Poyhonen (EVP)
  4. Waage Christian (Director)
  5. Craig A Johnson (Director)
  6. Kimberly Manhard (EVP)
  7. David Leslie Szekeres (COO)
  8. John Poyhonen (Insider)
  9. Kevin C Tang (Director)

Who are the major institutional investors of Heron Therapeutics?

Heron Therapeutics' top institutional shareholders include:
  1. Franklin Resources Inc. — 12.42%
  2. BlackRock Inc. — 7.79%
  3. Clearbridge Investments LLC — 3.38%
  4. JPMorgan Chase & Co. — 3.57%
  5. D. E. Shaw & Co. Inc. — 2.17%
  6. Oak Ridge Investments LLC — 2.30%

Which institutional investors are selling Heron Therapeutics stock?

Within the last quarter, HRTX stock was sold by these institutional investors:
  1. Rothschild & Co. Asset Management US Inc.
  2. Sei Investments Co.
  3. Highland Capital Management Fund Advisors L.P.
  4. Credit Suisse AG
  5. DSAM Partners London Ltd
  6. D. E. Shaw & Co. Inc.
  7. Point72 Asset Management L.P.
  8. Northern Trust Corp
In the last year, company insiders that have sold Heron Therapeutics company stock include:
  1. Barry D Quart (CEO)
  2. Kimberly Manhard (VP)
  3. John Poyhonen (EVP)
  4. Waage Christian (Director)

Which institutional investors are buying Heron Therapeutics stock?

Within the last quarter, HRTX stock was acquired by institutional investors including:
  1. Oak Ridge Investments LLC
  2. Millennium Management LLC
  3. Suvretta Capital Management LLC
  4. Hennion & Walsh Asset Management Inc.
  5. BlackRock Inc.
  6. Citigroup Inc.
  7. Palisade Capital Management LLC NJ
  8. JPMorgan Chase & Co.
During the last year, these company insiders have bought Heron Therapeutics stock:
  1. Barry D Quart (CEO)
  2. Kimberly Manhard (VP)
  3. John Poyhonen (EVP)
  4. Waage Christian (Director)
We're pulling 69%/yr — without margin, options, or gimmicks
I only buy one kind of stock. 37 of these cash cows are in my portfolio right now... and for every dollar invested in them they are sending us 69 cents in dividends. That's an effective yield of 69% a year-every year. All without leverage, options, or gimmicks.
Details here.
pixel